Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
- H. Depoortere, B. Zivkovic, +4 authors G. Bartholini
- Chemistry, Medicine
- The Journal of pharmacology and experimental…
- 1 May 1986
Zolpidem [N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide hemitartrate] is reported to be a rapid onset, short duration hypnotic that interacts at the benzodiazepine recognition… Expand
The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
- K. Lloyd, L. Davidson, O. Hornykiewicz
- Chemistry, Medicine
- The Journal of pharmacology and experimental…
- 1 December 1975
Post-mortem brain material from control and Parkinson's disease patients was examined to elucidate further the neurochemistry of this disease and to determine the mechanism of action of L-dopa as a… Expand
Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome.
- K. Lloyd, O. Hornykiewicz, +6 authors I. Fox
- Biology, Medicine
- The New England journal of medicine
- 5 November 1981
Different brain regions were removed post mortem from three patients with the Lesch-Nyhan syndrome and were examined for alterations in hypoxanthine-guanine phosphoribosyl transferase (HGPRT),… Expand
Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions
- K. Lloyd, O. Hornykiewicz
- Medicine
- Science
- 11 December 1970
The activity of L-dopa decarboxylase was greatly reduced in the striatum, less so in the hypothalamus, and unchanged in the cortex of brains of patients with Parkinson's disease. However, it appears… Expand
OCCURRENCE AND DISTRIBUTION OF AROMATIC l‐AMINO ACID (l‐DOPA) DECARBOXYLASE IN THE HUMAN BRAIN
- K. Lloyd, O. Hornykiewicz
- Chemistry, Medicine
- Journal of neurochemistry
- 1 June 1972
—The enzymatic decarboxylation of l‐DOPA was measured in isotonic dextrose homogenates of different regions of the human brain by estimating 14CO2 evolved from tracer amounts of d… Expand
Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action.
- Andrzej Pilc, K. Lloyd
- Biology, Medicine
- Life sciences
- 19 November 1984
Amitryptyline (10 mg/kg), desipramine (5 mg/kg), citalopram (10 mg/kg) and viloxazine (10 mg/kg) were administered to rats either acutely (decapitation 1 hr after i.p. injection) or subacutely (by… Expand
Pharmacological and behavioral profile of alpidem as an anxiolytic.
- B. Zivkovic, E. Morel, D. Joly, G. Perrault, D. Sanger, K. Lloyd
- Psychology, Medicine
- Pharmacopsychiatry
- 1 May 1990
Pharmacological and behavioral studies in mice and rats have shown that the imidazopyridine alpidem possesses anxiolytic activity with a profile which is substantially different from that of… Expand
Neurobiological substrates of tardive dyskinesia: the GABA hypothesis
- H. Fibiger, K. Lloyd
- Medicine
- Trends in Neurosciences
- 1 December 1984
Recent observations indicate that the dopamine receptor supersensitivity that occurs after chronic exposure to neuroleptic drugs fails to address or explain many known features of tardive dyskinesia.… Expand
Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid ([3H]GABA) binding in the human brain: Alterations in Parkinson's disease
- K. Lloyd, L. Shemen, O. Hornykiewicz
- Chemistry, Medicine
- Brain Research
- 27 May 1977
The regional distribution and properties of the sodium-independent "specific" binding of [3H]GABA to membranes prepared from human brains (control and Parkinsonian patients) have been investigated.… Expand
Cortical modulation of striatal function
- B. Scatton, P. Worms, K. Lloyd, G. Bartholini
- Biology, Medicine
- Brain Research
- 28 January 1982
The effect of bilateral section of the corticostriatal projections or of selective bilateral ablation of the frontal cortex on behavioral and biochemical parameters related to striatal function were… Expand